Cardiac hypertrophy, which is characterized by increased cell volume and metabolic and biochemical disorders, can also lead to reactivation of fetal cardiac genes such as atrial natriuretic factor (ANF) and β-myosin heavy chain (β-MHC) [8–10]. The gene discussed is NPPA; the disease is cardiac hypertrophy.